Hui Gan

Dr. Hui Gan


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 August 2024 in Journal of Global Health
Verified
Journal Article
Open access
HZHui Zeng
Hui Zeng
HGHui Gan
Hui Gan
YLYuanru Liu
Yuanru Liu
Baoqing SunBaoqing Sun
Baoqing Sun
Water, sanitation, and hygiene (WaSH) constitute a critical global environmental issue [1]. In an effort to substantially improve global access to safe water and sanitation, the United Nations (UN) General Assembly, with 193 member states, adopted Sustainable Development Goal (SDG) six targeting drinking water, sanitation, and hygiene [2]. Sustainable Development Goal 6 encompasses two specific […]

12 August 2024 in BMC Cancer
Verified
Journal Article
Open access
PDF file
ZCZhangkai J. Cheng
Zhangkai J. Cheng
HLhaiyang li
haiyang li
MLMingtao Liu
Mingtao Liu
XFXing Fu
Xing Fu
LLLi Liu
Li Liu
Baoqing SunBaoqing Sun
Baoqing Sun
Childhood leukemia is a prevalent form of pediatric cancer, with acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) being the primary manifestations. Timely treatment has significantly enhanced survival rates for children with acute leukemia. This study aimed to develop an early and comprehensive predictor for hematologic malignancies in children by analyzing nutritional biomarkers, key leukemia indicators, and granulocytes in their blood. Using a machine learning algorithm and ten indices, the blood samples of 826 children with ALL and 255 children with AML were compared to a control group of 200 healthy children. The study revealed notable differences, including higher indicators in boys compared to girls and significant variations in most biochemical indicators between leukemia patients and healthy children. Employing a random forest model resulted in an area under the curve (AUC) of 0.950 for predicting leukemia subtypes and an AUC of 0.909 for forecasting AML. This research introduces an efficient diagnostic tool for early screening of childhood blood cancers and underscores the potential of artificial intelligence in modern healthcare.

1 June 2018 in Microbial Drug Resistance
Verified
Journal Article
Closed access
HHHai Huang
Hai Huang
YZYanlin Zhang
Yanlin Zhang
SLSheng Li
Sheng Li
JWJun Wang
Jun Wang
JCJun Chen
Jun Chen
HGHui Gan
Hui Gan
Background: The Xpert MTB/RIF test (Cepheid, Sunnyvale, CA) can simultaneously detect the Mycobacterium tuberculosis (MTB) complex DNA and rifampicin (RFP) resistance and can rapidly determine RFP resistance and predict multidrug-resistant tuberculosis (MDR-TB). In this study, we analyzed clinical examination results of a hospital specializing in TB treatment in Wuhan, Hubei, China, and examined the use of traditional culture and drug-sensitive test (DST) results as a gold standard to assess the diagnosis value of the Xpert MTB/RIF test in RFP resistance and MDR-TB. Materials and Methods: A total of 2,910 specimens were received in the Mycobacteriology Laboratory, Wuhan Pulmonary Hospital, for Xpert MTB/RIF testing between December 2013 and December 2014. After the results were reviewed by exclusion criteria, 1,066 Xpert test results were eligible for our study. We then compared the Xpert test results with sputum acid-fast bacilli staining, cultures, and DST results. Results: In total, Xpert correctly identified 96.71% (147/152) RFP-resistant TB and 98.25% (898/914) RFP-sensitive TB specimens. Of the 147 RFP-resistant TB specimens detected by Xpert, 122 MDR-TB (82.99%) were identified by traditional culture and DST techniques. Conclusions: Xpert can simultaneously detect MTB and RFP resistance with high sensitivity and specificity. Thus, Xpert testing aids in saving a considerable amount of time in the diagnosis and treatment of MDR-TB.

15 December 2022 in Clinical & Experimental Allergy
Verified
Journal Article
Closed access
HGHui Gan
Hui Gan
WLWenting Luo
Wenting Luo
ZHZhifeng Huang
Zhifeng Huang
TZTeng Zhang
Teng Zhang
XHXiangqing Hou
Xiangqing Hou
Baoqing SunBaoqing Sun
Baoqing Sun

MLMingtao Liu
Mingtao Liu
HGHui Gan
Hui Gan
YLYilu Lin
Yilu Lin
RLRunpei Lin
Runpei Lin
MXMingshan Xue
Mingshan Xue
Baoqing SunBaoqing Sun
Baoqing Sun
Background: The credible materials about the burden of asthma in China when compared to other countries in the group of twenty (G20) remain unavailable. Objectives and design: Following the popular analysis strategy used in the Global Burden of Disease Study, the age-, sex-, country-specific prevalence, and disability-adjusted life years (DALYs) of asthma in China were analyzed. Meanwhile, the comparison in trends between China and other countries in the G20 was also evaluated. Results: In 2019, asthma was the 8th leading cause of the DALYs’ burden of 369 diseases in China. From 1990 to 2019, the age-standardized prevalence and DALY rates of asthma in China decreased by 14% and 51%, respectively; further, the decline rate of DALYs was much higher than the global average (−51%: −43%). It is worth noting that the overall population age-standardized DALYs rate of asthma in China was the lowest in the G20 during 2019 (102.81, 95% UI: (72.30,147.42)/100,000). Moreover, the age-standardized asthma prevalence rate peaks in both childhood (178.14, 95% UI: (90.50, 329.01)/100,000) and the elderly (541.80, 95% UI: (397.79, 679.92)/100,000). Moreover, throughout the study, subjects in the 5 to 9 years old interval were a constant focus of our attention. Conclusions: The disease burden of asthma has varied greatly by gender and age over the past 30 years. In contrast to the increasing burden in most other G20 countries, the age-standardized prevalence rate of asthma shows a significant decreasing trend in China, however, the age-standardized DALYs rate shows a fluctuating change, and has even shown a rebound trend in recent years.

25 June 2020 in Journal of Medical Virology
Verified
Journal Article
Open access
PDF file
LRLianguo Ruan
Lianguo Ruan
YZYan Zhang
Yan Zhang
YLYanhe Luo
Yanhe Luo
XYXiaoli Yu
Xiaoli Yu
YZYan Zeng
Yan Zeng
MLMao Liu
Mao Liu
Click on the article title to read more.